Growth Metrics

Koninklijke Philips (PHG) Return on Equity (2010 - 2012)

Koninklijke Philips' quarterly Return on Equity came in at 0.0% in Q4 2012, little changed year-on-year from 0.0% in Q1 2012, and down 88.22% quarter-over-quarter from 0.0% in Q3 2012.

Koninklijke Philips has reported Return on Equity for 3 years, with the latest figure at 0.0% in Q4 2012.

  • For the quarter ending Q4 2012, Return on Equity changed 0.0% year-over-year to 0.0%; the trailing twelve-month figure through Dec 2012 stood at 0.0% (changed 0.0% YoY), and the FY2025 full-year result was 0.0%, changed 0.0% from the prior year.
  • Return on Equity for Q4 2012 stood at 0.0%, down from 0.0% in the prior quarter.
  • The five-year high for Return on Equity was 0.0% in Q3 2012, with the low at 0.0% in Q3 2011.
  • Average Return on Equity over 3 years is 0.0%, with a median of 0.0% recorded in 2010.
  • Peak annual rise in Return on Equity reached 0 bps in 2011, while the deepest fall reached 0 bps in 2011.
  • Tracing PHG's Return on Equity over 3 years: stood at 0.0% in 2010, then tumbled by 178 bps to 0.0% in 2011, then soared by 270 bps to 0.0% in 2012.
  • The last three Return on Equity figures came in at 0.0% (Q4 2012), 0.0% (Q3 2012), and 0.0% (Q4 2011), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.00%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.00%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.00%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.00%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.00%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.00%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.00%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn 0.00%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2012 0.00%
Sep 30, 2012 0.00%
Dec 31, 2011 0.00%
Sep 30, 2011 0.00%
Dec 31, 2010 0.00%